scispace - formally typeset
P

Pradyumna D. Phatak

Researcher at University of Rochester

Publications -  34
Citations -  1033

Pradyumna D. Phatak is an academic researcher from University of Rochester. The author has contributed to research in topics: Hemochromatosis & Population. The author has an hindex of 10, co-authored 34 publications receiving 997 citations. Previous affiliations of Pradyumna D. Phatak include Rochester General Health System.

Papers
More filters
Journal ArticleDOI

Mutation Analysis in Hereditary Hemochromatosis

TL;DR: The DNA of 147 patients of European origin clinically diagnosed with idiopathic hemochromatosis and 193 controls was examined for mutations of the HLA-H gene at nt 845 and nt 187, suggesting the presence of as yet undiscovered mutations existing in trans with 845A and in linkage disequilibrium with 187G.
Journal ArticleDOI

Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey

TL;DR: The rationale for ongoing international efforts to increase awareness of type 1 von Willebrand disease as a cause for menorrhagia and to improve the quality of life in females with known vWD is supported.
Journal ArticleDOI

Prevalence of Hereditary Hemochromatosis in 16 031 Primary Care Patients

TL;DR: The goal was to estimate the prevalence of hemochromatosis and to establish the feasibility of screening for hemochROMatosis in a large primary care population.

Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload

TL;DR: In this paper, the authors performed exome sequencing of DNA from 35 male HFE C282Y homozygotes with either markedly increased iron stores (n=22; cases) or with normal or mildly increased iron levels (n =13; controls).
Journal ArticleDOI

Prevalence and Penetrance of HFE Mutations in 4865 Unselected Primary Care Patients

TL;DR: The prevalence of the common HFE mutations is the same in the population as previously described and the penetrance of C282Y/C282Y is significant and the clinical penetrance is low.